Press Releases

September 13, 2021 Devonian Health Group Announces Closing of a Private Placement

September 09, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS

August 31, 2021 DEVONIAN HEALTH GROUP ANNOUNCES EXCLUSIVE DISTRIBUTION, SALES AND MARKETING AGREEMENT FOR PURGENESIS™ ANTI-AGING PRODUCTS IN MIDDLE EAST COUNTRIES

August 26, 2021 DEVONIAN HEALTH GROUP INC. ANNOUNCES ITS PARTICIPATION AT VIRTUAL BIOPLUS INTERPHEX KOREA 2021 TO TAKE PLACE FROM AUGUST 31st TO SEPTEMBER 15, 2021

July 28, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER

July 27, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN CHICAGO (USA) TODAY JULY 27, 2021

July 20, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN LOS ANGELES (USA) TODAY JULY 20, 2021

June 14, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR VANCOUVER TODAY JUNE 14, 2021

June 03, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES FOR MONTREAL AND EAST OF CANADA TODAY JUNE 3RD, 2021

May 26, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES IN BOSTON (USA) TODAY MAY 26, 2021

May 13, 2021 DEVONIAN HEATH GROUP INC. TO PRESENT AT THE CANADA INDIA HEALTHCARE SUMMIT 2021

May 11, 2021 DEVONIAN HEATH GROUP INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON THURSDAY, MAY 13, 2021

April 14, 2021 DEVONIAN HEALTH GROUP INC. RETAINS RENMARK FINANCIAL COMMUNICATIONS INC. TO PROVIDE INVESTOR RELATIONS SERVICES

March 30, 2021 Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering use of Thykamine™ for the treatment of Cardiovascular Diseases

March 25, 2021 Devonian Health Group provides more details on Previously Announced Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Population with Mild-to-Moderate Atopic Dermatitis and the Grant of Stock Options

March 05, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS

February 18, 2021 Devonian Health Group Announces Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Patients with Mild-to-Moderate Atopic Dermatitis

January 28, 2021 Devonian Health Group Announces voting results of the Annual General and Special Meeting

January 22, 2021 DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER